English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

© 2018 Eldar-Finkelman H. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License Neurodegenerative disorders spread over millions of people worldwide and are one of the greatest threats to public health. The prevalence of these disorders is expected to grow exponentially within the next few decades due to the increase in aging population and life span with a resultant enormous social and financial burdens. There is no adequate therapies to these disorders. Therefore, there is an urgent need to accelerate the discovery and development of effective treatments.

Novel Modality of GSK-3 Inhibition For Treating Neurodegeneration